Claims
- 1. 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone represented by the formula: ##STR2##
- 3. A pharmaceutical composition useful for immunosuppression in mammals containing a pharmaceutically acceptable carrier together with a therapeutically effective amount of 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone.
- 4. A pharmaceutical composition in dosage unit form useful for immunosuppression in mammals containing a therapeutically effective amount of 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone together with a pharmaceutically acceptable carrier.
- 5. A pharmaceutical composition useful for immunosuppression in mammals containing a pharmaceutically acceptable carrier together with a therapeutically effective amount of 2-(5-methoxymethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone.
- 6. A pharmaceutical composition in dosage unit form useful for immunosuppression in mammals containing a therapeutically effective amount of 2-(5-methoxymethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone together with a pharmaceutically acceptable carrier.
- 7. A method of inhibiting the immune response of a mammal in need of such inhibition which comprises administering an amount which is effective to effect such inhibition of 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone.
- 8. The method of claim 7 wherein the mammal is a human.
- 9. The method of claim 7 wherein the mammal is an animal.
- 10. A method of inhibiting the immune response of a mammal in need of such inhibition which comprises administering an amount which is effective to effect such inhibition of 2-(5-methoxymethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone.
- 11. The method of claim 10 wherein the mammal is a human.
- 12. The method of claim 10 wherein the mammal is an animal
RELATED APPLICATIONS
This application is a continuation-in-part of application Ser. No. 225,964 filed July 28, 1988 now abandoned which is, in turn, a continuation-in part of application Ser. No. 89,525 filed Aug. 26, 1987.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4620014 |
Szent-Gyorgyi et al. |
Oct 1986 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
225964 |
Jul 1988 |
|
Parent |
89525 |
Aug 1987 |
|